Projects View

AbbVie to Invest €150 Million in New Research and Development Facility, Germany

Specifications:

Name:

AbbVie to Invest €150 Million in New Research and Development Facility, Germany

Location:

Germany

Company:

AbbVie

Estimated Cost:

€150 Million

Source:

https://news.abbvie.com

Introduction:

AbbVie has commenced construction on a new central research facility named “LUnA” (LUdwighafens neue Arbeitswelt) at its site in Rhineland-Palatinate. The company is investing approximately €150 million in this project, which represents its second largest R&D hub globally.

Features:

The cutting-edge research and laboratory complex will be located on AbbVie's main campus, accommodating over 300 researchers and scientists. The facility will feature modern, sustainable infrastructure designed to foster flexible working conditions and facilitate enhanced scientific collaboration across various research domains. It will also incorporate advanced automation and digital research capabilities.

This substantial investment underscores AbbVie’s commitment to its Rhineland-Palatinate location, which employs more than 2,000 people. The site plays a pivotal role in AbbVie's global network, contributing significantly to the advancement of the company's pipeline with the aim of developing new therapies for serious conditions in oncology, neuroscience, and immunology that could improve the lives of millions of patients.

The research building is projected to be completed by 2027.